Choice of the comparator for signal generation in pharmacovigilance databases:: Impact on detection thresholds

被引：0
|
作者：
Pariente, A. [1 ,2 ,3 ]
Didailler, M. [3 ]
Avillach, P. [3 ]
Miremont-Salame, G. [1 ]
Fourrier-Reglat, A. [1 ,3 ]
Haramburu, F. [1 ,3 ]
Moore, N. [1 ,2 ,3 ]
机构：
[1] INSERM, U657, Bordeaux, France
[2] Univ Bordeaux 2, Dept Pharmacol, F-33076 Bordeaux, France
[3] CHU Bordeaux, Dept Pharmacol, Bordeaux, France
来源：
DRUG SAFETY | 2007年 / 30卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：924 / 924
页数：1
相关论文
共 50 条
  • [1] Choice of the comparator for signal generation in pharmacovigilance databases: Impact on detection thresholds
    Pariente, Antoine
    Didailler, Marie
    Fourrier-Reglat, Annie
    Haramburu, Francoise
    Moore, Nicholas
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S251 - S252
  • [2] Choice of the comparator for signal generation in pharmacovigilance databases: impact on detection thresholds
    Pariente, A.
    Didailler, M.
    Haramburu, F.
    Moore, N.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2007, 21 : 63 - 63
  • [3] Opportunity in Diversity: Merging Healthcare Databases in Europe for Safety Signal Detection in Pharmacovigilance
    Coloma, Preciosa
    Schuemie, Martijn
    Trifiro', Gianluca
    Herings, Ron
    Hippisley-Cox, Julia
    Gini, Rosa
    Molokhia, Mariam
    Mazagglia, Giampiero
    Giaquinto, Carlo
    Corrao, Giovanni
    Pedersen, Lars
    Sturkenboom, Miriam
    van der Lei, Johan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S184 - S184
  • [4] Hypothesis-free signal detection in healthcare databases: finding its value for pharmacovigilance
    Bate, Andrew
    Hornbuckle, Ken
    Juhaeri, Juhaeri
    Motsko, Stephen P.
    Reynolds, Robert F.
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2019, 10
  • [5] Lack of transparency, poor reporting and overinterpretation of disproportionality analyses for signal detection in pharmacovigilance databases
    Khouri, C.
    Revol, B.
    Lepelley, M.
    Mouffak, A.
    Bernardeau, C.
    Salvo, F.
    Pariente, A.
    Roustit, M.
    Cracowski, J. L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 : 88 - 89
  • [6] The impact of exposure model misspecification on signal detection in prospective pharmacovigilance
    van Gaalen, Rolina D.
    Abrahamowicz, Michal
    Buckeridge, David L.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 (05) : 456 - 467
  • [7] Thoughts on Signal Detection in Pharmacovigilance
    Saad A.W. Shakir
    Drug Safety, 2007, 30 : 603 - 606
  • [8] Principles of signal detection in pharmacovigilance
    Meyboom, RHB
    Egberts, ACG
    Edwards, IR
    Hekster, YA
    deKoning, FHP
    Gribnau, FWJ
    DRUG SAFETY, 1997, 16 (06) : 355 - 365
  • [9] Principles of Signal Detection in Pharmacovigilance
    Ronald H. B. Meyboom
    Antoine C. G. Egberts
    I. Ralph Edwards
    Yechiel A. Hekster
    Fred H. P. de Koning
    Frank W. J. Gribnau
    Drug Safety, 1997, 16 : 355 - 365
  • [10] Thoughts on signal detection in pharmacovigilance
    Shakir, Saad A. W.
    DRUG SAFETY, 2007, 30 (07) : 603 - 606
12345